Your CMO Isn’t Meeting Expectations - Now What?

How to Have the Hard Conversation Without Burning the Relationship

If you're leading manufacturing operations for a biotech — whether you're managing a clinical pipeline or a commercial asset — there's a good chance your relationship with at least one Contract Manufacturing Organization has hit a rough patch. Maybe turnaround times have slipped. Maybe deviations are piling up. Maybe the responsiveness that won you over during the vendor selection process has quietly disappeared.

You're not alone. Across the biotech industry, sponsor-CMO friction is one of the most persistent operational challenges we see. And the stakes couldn't be higher — when your CMO underperforms, it's your patients, your timelines, and your regulatory standing on the line.

So how do you address it without torching a relationship you've invested months (or years) building?

Start by Separating Frustration from Facts

Before picking up the phone or drafting that email, take a step back. Frustration is valid, but it's not a strategy. The most effective conversations start with a clear, data-driven picture of where your CMO is falling short.

Pull together the specifics: batch records with recurring deviations, response times on CAPAs, missed delivery windows, communication gaps during investigations. The goal isn't to build a case against your CMO — it's to create a shared understanding of reality. When you walk into the conversation with documentation rather than emotion, you immediately shift the dynamic from adversarial to collaborative.

Frame It as a Partnership Problem, Not a Blame Game

Here's where most biotech leaders get it wrong. The instinct is to come in hot — "You're not meeting our expectations, and here's why." That puts your CMO on the defensive before the conversation even starts.

Instead, reframe the issue as a shared challenge. Something like: "We're seeing gaps between where we are and where we need to be, and I want to work through this together." This isn't about being soft. It's about being strategic. A CMO that feels attacked will give you compliance. A CMO that feels like a partner will give you commitment — and in this industry, that difference matters.

Get Specific About What "Better" Looks Like

One of the biggest breakdowns in sponsor-CMO relationships is a misalignment on expectations. Your CMO may genuinely believe they're performing well because the bar was never clearly defined — or because it shifted as your program evolved from Phase I to Phase III, or from clinical to commercial.

Lay out what success looks like in concrete, measurable terms. That might include target response times for deviation investigations, agreed-upon communication cadences, quality metrics tied to batch release timelines, or defined escalation pathways when issues arise. When expectations are documented and mutually agreed upon, accountability becomes a shared responsibility rather than a one-sided demand.

Listen — Really Listen — to Their Side

This is the part that's easy to skip but hard to overstate. Your CMO may be dealing with capacity constraints, staffing challenges, or competing priorities from other sponsors that you're not aware of. None of that excuses poor performance, but understanding their reality gives you better leverage to negotiate meaningful improvements.

Ask direct questions: "What's getting in the way of meeting these timelines?" or "Where are you feeling the most strain right now?" You might uncover operational bottlenecks that can be solved collaboratively — or you might discover that your program simply isn't getting the prioritization it deserves, which is a very different (and important) conversation to have.

Build in Accountability Without Building a Wall

After you've aligned on expectations and heard their perspective, the next step is creating a structured follow-up cadence. This doesn't mean micromanaging — it means establishing joint governance that keeps both sides honest.

Consider implementing regular quality review meetings with defined KPIs, a shared tracker for open action items and their owners, and a clear escalation framework that both parties agree to in advance. The goal is a rhythm of accountability that prevents small issues from compounding into relationship-ending ones. Think of it as preventive maintenance for your most critical outsourcing partnership.

Know When the Conversation Needs to Escalate

Sometimes, despite your best efforts, the performance gap doesn't close. If you've had the conversation, set clear expectations, given adequate time for improvement, and the needle hasn't moved — it's time to escalate. That might mean engaging executive leadership on both sides, initiating a formal remediation plan, or beginning the difficult process of evaluating alternative manufacturing partners.

This isn't failure. It's responsible stewardship of your program and your patients' interests. The key is making sure you've done the work upfront so that if escalation becomes necessary, it's grounded in data and good faith — not frustration.

The Bottom Line

Your CMO relationships are among the most consequential partnerships in your operation. When they work well, they accelerate your path to patients. When they don't, the ripple effects hit every part of your organization.

Having the hard conversation isn't optional — but having it well is a choice. Lead with data, frame it as a partnership, get specific about expectations, and build in the structure to keep things on track. That's how you maintain the relationship and raise the bar at the same time.

Verant Consulting Group partners with biotech companies to optimize manufacturing operations and strengthen outsourcing relationships. If your CMO partnerships need a reset, let's talk.